Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Bright White Light Therapy During Cocaine Detoxification

Official title: Bright Light Therapy During Inpatient Cocaine Detoxification

Run by Hôpital le Vinatier · NCT07545798 · Data updated 2026-11-12

This study tests whether adding bright light therapy to inpatient cocaine detoxification helps people see if they feel better and maintain detoxification.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment256 (estimated)
SponsorHôpital le Vinatier
Academic / other
Locations1 site (Bron, Auvergne-Rhône-Alpes)
StatusRecruiting
StartedSeptember 12, 2025
Main results expectedSeptember 30, 2029
Study endsDecember 30, 2029
Registry record updatedJune 12, 2026
Trial IDNCT07545798 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years and older with DSM-5 cocaine use disorder undergoing planned inpatient supervised detoxification and with health insurance coverage.

Probably not a fit

Individuals with non-stabilized psychiatric or somatic conditions or those using certain contraindicated medications or with retinopathy or other vision issues may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

CokeLux is a multicenter, randomized, sham-controlled, double-blind trial evaluating the use of a medical light therapy device during hospital-based cocaine detoxification. After a 10 to 17 day inpatient detox, participants will discontinue the intervention but continue follow-up data collection for one month. The study compares active light therapy to a sham device, with outcomes assessed in the hospital and after discharge. The trial design includes pre-hospitalization assessment and longitudinal data collection to monitor safety, withdrawal symptoms, and abstinence-related metrics. It targets adults with cocaine use disorder undergoing supervised detoxification and follows standard clinical research governance for medical devices.

Why it matters

Potential benefit: If successful, bright light therapy could support withdrawal management and improve recovery trajectories for patients undergoing cocaine detoxification.

How similar studies have gone: Previous studies using non-pharmacologic light therapy have shown potential benefits in mood and circadian regulation in related settings, but this specific inpatient cocaine detox context is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female, 18 years of age or older
* DSM-5 criteria for cocaine use disorder
* Positive urine screen for cocaine
* Hospitalization for supervised cocaine detoxification planned within the four upcoming weeks
* The patients must be insured or beneficiary of a health insurance plan
* Signed and dated informed consent document(s) indicating that the subject has been informed of all pertinent aspects of the trial

Exclusion Criteria:

* Non-stabilized opioid use disorder or other psychostimulant use disorder (e.g., amphetamine, met-amphetamine, cathinones, methylphenidate…)
* Non-stabilized psychiatric disorder or somatic disease, which is considered incompatible with inclusion by the investigator
* Current treatment with methylphenidate, modafinil, solriamfetol, melatonin pitolisant, naltrexone, or bupropion.
* Contraindication to light therapy: retinopathy, pigmentary retinitis, diabetic retinopathy, macular degeneration, glaucoma, recent (i.e., less than three month) eye surgery. (If there is any doubt about an ophthalmological contraindication, a specialist opinion will be requested)
* Tutorship
* Pregnant or breastfeeding women: the performance of a pregnancy test before inclusion for women of childbearing age
* Persons deprived of their liberty by a judicial or administrative decision
* Persons participating in other research with an exclusion period still in progress at pre-inclusion

Where it's running

  • Centre Hospitalier Le Vinatier
    Bron, Auvergne-Rhône-Alpes, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.